Skip To Main Content
Na Ying on Muck Rack

Na Ying

As seen in: Wiley Online Library, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Na

Contact Na, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Transport Pathways of Ozone in Beijing–Tianjin–Hebei Based on Causal Networks

|
By Zhen Song, Engineering Hebei, Na Ying
| Wiley Online Library Verified
1 Introduction Recently, PM2.5 concentrations in China have declined significantly, whereas ozone (O3) pollution has occurred with increasing frequency (Wang et al. 2020; Chu et al. 2021). Persistent O3 pollution has serious consequences, including reductions in crop yields, elevated risks of respiratory and cardiovascular diseases, and substantial threats to human productivity and well-being (Orellano et al. 2020; Xiao et al. 2021; Feng et al. 2014).
Open in Who Shared Issue with article?

Object-Environment Fusion of Visual System for Automatic Pear Picking

|
By Yuxing Liu, Na Ying, Chunsheng Guo
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (671) Issue with article?

Engineering a pH‐responsive polymeric micelle co‐loaded with paclitaxel and triptolide for breast cancer therapy

|
By Mengmeng Zhang, Na Ying, Jie Chen, Liwen Wu
| Wiley Online Library Verified
1 INTRODUCTION Breast cancer added 2.26 million people worldwide in 2020, overtaking lung cancer (2.21 million) as the number one cancer worldwide.1 Traditional cancer treatments include surgery, radiotherapy, chemotherapy, and immunotherapy.2 Drug therapy is an integral part of the long-term treatment of almost all breast cancer patients.3 Paclitaxel (PTX), a first-line treatment drug for breast cancer, is a microtubule stabilizer that accelerates microtubule polymerization and...
Open in Who Shared Issue with article?
See all 5 articles